HCW Biologics is trading 10.1% up at $3.52 in pre-market, extending a sharp multi-day surge fueled by a $1.6 million private placement.
- The move has sparked strong investor enthusiasm, with the stock already posting significant gains on July 30 and July 31.
- Traders continue to pile into the low-float biotech name, sustaining the upward momentum seen late last week.